X0202 4/A 2008-01-11 2008-01-15 0 0000878088 PAR PHARMACEUTICAL COMPANIES, INC. PRX 0001402404 LUBATKIN VERONICA C/O PAR PHARMACEUTICAL COMPANIES, INC. 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 0 1 0 0 Exec VP, CFO Common Stock 2008-01-11 4 A 0 36849 0 A 74025 D Award of shares of Restricted Stock under the Company's 2004 Performance Equity Plan. 33% of the shares of Restricted Stock vest as follows: 25% vest on the first anniversary of the date of grant and an additional 25% vest on each anniversary thereafter until the 33% are fully vested; 67% of the shares of Restricted Stock vest as follows: over a three-year period, upon the achievement by the Company of defined goals of Total Returns to Shareholders relative to a defined peer group of pharmaceutical companies. The closing price of the Company's Common Stock as reported by The New York Stock Exchange, Inc. on the date of grant was $21.71. This Amendment is being filed to correct the total number of securities beneficially owned in Column 5 of Table I; includes all outstanding shares of Restricted Stock and Restricted Stock Units held by Ms. Lubatkin. /s/ Marian E. Gustafson for Veronica Lubatkin 2008-01-17